Catherine Dumont, MD

Catherine Dumont, MD is a physician with clinical and research training in endocrinology and growth hormone therapeutics. Medical training completed in Montréal with post-graduate research in hormonal peptide therapeutics in the United States. Her work has addressed GHRH analog applications including lipodystrophy-related indications and growth hormone axis disorders.

She completed a research fellowship in Hormonal Therapeutics at Johns Hopkins Endocrinology following residency training at the McGill University Health Centre. Her clinical research background includes experience evaluating the evidence base for GHRH-based compounds, including tesamorelin, across approved and investigational indications.

As medical reviewer for Tesamorelin Sale, Dr. Dumont evaluates the site's educational content for medical accuracy in describing tesamorelin's clinical applications, approved and investigational use contexts, mechanism of action, and relevant safety and dosing considerations.